|
|||||
|
|
Response to comment on article by Jit et al. “The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe” |
|
| Authors: | Mark Jit |
| Affiliation: | Modelling and Economics Unit, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom; Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium;a Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Netherlands b Centre for Prevention and Health Services Research; National Institute for Public Health and the Environment, Netherlands; National Institute for Health and Welfare (THL), Finland; Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France; London School of Hygiene and Tropical Medicine, United Kingdom;a Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France b Avenir-ATIP, INSERM U995, Lille, France; Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium |
| Abstract: | |
| Keywords: | Rotavirus Vaccination Cost-effectiveness |
| 本文献已被 ScienceDirect 等数据库收录！ | |